Gauge the commercial outlook for new brands, generics and other key market events
Review current treatments, assess unmet needs and corresponding opportunities and profile emerging therapies
180+ indications in therapy areas including oncology, rare diseases, cardiovascular and more. To view indication specific research click here.
Based on DRG’s epidemiology, KOL interviews and DRG expert opinion
Annualized, bottom-up 10-year forecasts for the G7 segmented by class, brand/generic and population
Updated quarterly based on regulatory, clinical and market events
Solution Feature Enhancement
Market Forecast Dashboard provides enhanced data-mining capabilities with auto-generated charts and figures to create customized views based on specific populations, geographies, drugs/ drug classes and more.
Want to learn more?
Contact us to connect with a DRG specialist on how we can help you get actionable insights to optimize long-term disease strategy